Speakers
Alan Go
Regional Medical Director
Kaiser Permanente
Day One
Wednesday, September 8, 2021
11:15 am | Panel Discussion: Identifying Where Different DCT Opportunities are Globally
Anna Yang
Senior Medical Science Director
Genentech
Day One
Wednesday, September 8, 2021
9:30 am | Case Study: Meeting Patients and Health Systems Where They Are
4:30 pm | Panel Discussion: Examining DCT Patient Engagement Issues
Daniel Karlin
Chief Medical Officer
MindMed
Day One
Wednesday, September 8, 2021
4:30 pm | Panel Discussion: Examining DCT Patient Engagement Issues
Day Two
Thursday, September 9, 2021
3:45 pm | Panel Discussion: Incorporating Underrepresented Diseases into DCTs
Esther Howard
Oncology Advisor
THREAD Research
Day Two
Thursday, September 9, 2021
9:00 am | Establishing & Conducting an Oncology DCT
Hassan Kadhim
Senior Director, Head of Clinical Trial Business Capabilities
Bristol Myers Squibb
Day One
Wednesday, September 8, 2021
11:15 am | Panel Discussion: Identifying Where Different DCT Opportunities are Globally
Day Two
Thursday, September 9, 2021
3:45 pm | Panel Discussion: Incorporating Underrepresented Diseases into DCTs
Heidi Johnson
Director, DCT Operations, DCT Strategy & Implementation
Bayer
Day One
Wednesday, September 8, 2021
11:15 am | Panel Discussion: Identifying Where Different DCT Opportunities are Globally
10:15 am | Proactively Preparing for Successful Deployment of a DCT
Imran Shakur
Associate Director, Clinical Supply Capabilities
Biogen
Day One
Wednesday, September 8, 2021
11:15 am | Panel Discussion: Identifying Where Different DCT Opportunities are Globally
Isaac Rodriguez- Chavez
Senior Vice President of Scientific & Clinical Affairs
ICON
Day One
Wednesday, September 8, 2021
12:30 pm | Planning & Adapting to New DCT Regulations
9:45 am | Understanding the Multiple Factors & Trends Influencing DCT Designs & Deployment
8:50 am | Opening Remarks
James Hacunda
Data Sciences Institute, Research & Development Digital Strategy Lead
Takeda
Day Two
Thursday, September 9, 2021
1:30 pm | Increasing DCT Patient Retention Rates
Jeremy Price
Senior Director, Clinical Innovation & Strategic Partnerships
Pfizer
Day One
Wednesday, September 8, 2021
9:00 am | Panel Discussion: Achieving Buy-in & Adoption from Stakeholders for DCTs
Lewis Millen
Global Clinical Sciences & Operations Lead
UCB
Day One
Wednesday, September 8, 2021
11:15 am | Panel Discussion: Identifying Where Different DCT Opportunities are Globally
Day Two
Thursday, September 9, 2021
4:30 pm | The Future of DCTs - Lessons Learned & Thinking Beyond Covid
Maimah Karmo
Patient Advocate & CEO
Tigerlily Foundation
Day One
Wednesday, September 8, 2021
4:30 pm | Panel Discussion: Examining DCT Patient Engagement Issues
9:00 am | Panel Discussion: Achieving Buy-in & Adoption from Stakeholders for DCTs
Rakesh Maniar
Head of eClinical Technologies, Global Data Management & Standards, Clinical Trial Operations
Merck
Day Two
Thursday, September 9, 2021
11:30 am | Utilizing Digital Capabilities while Conducting a DCT
Sandeep Bhat
Senior Leader, Digital Engagement, Implementation & Global Clinical Operations
GSK
Day One
Wednesday, September 8, 2021
11:15 am | Panel Discussion: Identifying Where Different DCT Opportunities are Globally
9:00 am | Panel Discussion: Achieving Buy-in & Adoption from Stakeholders for DCTs
Savo Topic
Associate Director Digital Strategy, R&D
Takeda
Day Two
Thursday, September 9, 2021
11:00 am | Creating & Executing Resilient Clinical Trials by Incorporating DCTs
Syneos Health Representative
Taras Carpiac
Executive Director, Global Development Operations
Amgen
Day One
Wednesday, September 8, 2021
3:30 pm | Considering Optionality and Agility while Planning a DCT
Tracey Robertson
Global Clinical Development & Operations Patient & Site Engagement Process Lead
Boehringer Ingelheim
Day One
Wednesday, September 8, 2021
2:30 pm | Designing a Clinical Trail Around the Patient
TrialCard Representative
Wendi Lau
Senior Director Clinical Development Operations, TA Lead Specialty Medicine
AbbVie
Day One
Wednesday, September 8, 2021